Hualan Biological Engineering Sets Up Asia’s Largest Blood Products Base
This article was originally published in PharmAsia News
Hualan Biological Engineering has finished the construction of its blood products base in Fuling, Sichuan province. Covering 60,000 square meters, the RMB 280 million investment houses 10,000 square meters of factory floor space. When it officially commences operation next year, the base will process 1,000 tons of blood plasma annually with output reaching RMB 480 million. This will make it Asia's largest blood product base and among the world's top three facilities. (Click here for more - Chinese Language)
You may also be interested in...
The US HHS played defense on 20 September, pushing back on suggestions that secretary Alex Azar’s recent move to exert control over regulations by signing off on them was a power play aimed at the FDA. Meanwhile, former agency head Scott Gottlieb says it’s “the wrong move at the wrong time.”
With list due 4 November, there may not be time for public comment. Meanwhile, where will biopharma find fill/finish capacity?
Lorbrena is approved as a second-line treatment for ALK-positive NSCLC but Pfizer believes data from the first-line Phase III CROWN study makes the drug a serious competitor to standard of care Alecensa in the first-line setting.